MRD testing promises sharper DLBCL response tracking than PET scans, cutting false positives, biopsies, and guiding therapy ...

Stage 1 mixed cellularity Hodgkin lymphoma is often highly treatable, and many patients achieve long-term remission after frontline therapy. Advances in chemotherapy, radiation techniques and targeted ...

MRD testing in lymphoma grows fast, but varying assays and limited guidelines leave clinicians guessing; trials and standards clarify care.

The Biden era policy moved to reduce emissions by nearly 90 percent as the chemical, when exposed to it long-term ...

HealthDay News — In guidelines issued by the American Society of Hematology and published online Feb. 11 in Blood Advances, recommendations are presented for frontline management of acute ...

New ASH guidelines outline optimal management for a subgroup of patients with leukemia that historically has been challenging to treat.Two papers published simultaneously in Blood Advances address ...

A new statistical analysis of patients with follicular lymphoma, made possible by 15 years of follow-up data from a SWOG and ...

According to a study out of the Brigham and Women’s Hospital and Harvard Medical School, there is a link between consumption of Aspartame, as well as sugar-containing soda and the risk of lymphoma and ...

Annual meeting moves to the New York Marriott Marquis on October 13-16, marking a new chapter and providing a refreshed setting for in-person oncology learning. Clinicians are managing more options ...

The FDA has approved AstraZeneca’s Calquence (acalabrutinib), for adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). Combined with venetoclax (brand name ...

Many people learn they have lymphoma after they or their primary care provider (PCP) notices signs or symptoms. Some people develop symptoms quickly and are diagnosed within days or weeks. For others, ...